Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Preferred Stock Liabilities (2019)

Historic Preferred Stock Liabilities for Harmony Biosciences Holdings (HRMY) over the last 1 years, with Q4 2019 value amounting to $411.3 million.

  • Harmony Biosciences Holdings' Preferred Stock Liabilities changed N/A to $411.3 million in Q4 2019 from the same period last year, while for Dec 2019 it was $411.3 million, marking a year-over-year change of. This contributed to the annual value of $411.3 million for FY2019, which is N/A changed from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Preferred Stock Liabilities stood at $411.3 million for Q4 2019.
  • Over the past 5 years, Harmony Biosciences Holdings' Preferred Stock Liabilities peaked at $411.3 million during Q4 2019, and registered a low of $411.3 million during Q4 2019.